Baby Cost: $7,600
The cost of a birth–from prenatal care through delivery–averages roughly $7,600, according to the Agency for Healthcare Research and Quality. The total, calculated in 2004 dollars, includes payments for hospital childbirth, prenatal office visits, prescription medicines, and other services. AHRQ also found that average spending for prenatal care for women with private insurance and women with Medicaid was about the same–approximately $2,000. However, inpatient delivery costs differed: $6,520 for those with private insurance and $4,577 on average for Medicaid patients. On average, privately insured women paid about 8% of their total expenses out of pocket, while women on Medicaid paid only about 1% out of pocket. Only 23% of women had some prescription drug expenses associated with their pregnancy and the median amount of these expenses was $640. About three-quarters of all prescription drug expenses during pregnancy were for nutritional products such as prenatal vitamins.
Verdict $135M in HT Case
A jury in Reno, Nev., awarded about $135 million to three women who contended that their breast cancer diagnoses were caused by hormone replacement drugs manufactured by Wyeth; the company said it would appeal. This is the seventh case to reach a verdict since trials began in HT litigation earlier this year, and the first case Wyeth has lost outright, although the verdict against Wyeth in one trial was overturned and judgment entered in favor of the drug manufacturer, and two other plaintiffs' verdicts were thrown out, with new trials ordered. The company faces more than 5,000 lawsuits over its products Premarin and Prempro. Wyeth has argued in court that it told physicians and patients about the elevated breast cancer risks and included them on the drugs' labels.
California Enacts AIDS Bill
California Gov. Arnold Schwarzenegger (R) has signed into law a measure that advocates say removes a major barrier to HIV testing by requiring a patient to give simple consent, rather than informed consent, prior to the test. The legislation, which had almost unanimous support in the California Legislature, also will streamline some of the procedures a physician must follow in testing a pregnant woman. The law “normalizes the process of testing by making HIV screening a routine part of medical care,” said Joseph Terrill of the Sacramento-based AIDS Healthcare Foundation, adding that it also has provisions to maintain and safeguard patient confidentiality as well as an individual's right to choose whether to test.
Hispanic Women Confused on HPV
Hispanic women are less aware than other women that human papillomavirus (HPV) is sexually transmitted, according to a survey conducted by the American Social Health Association. However, more Hispanic women than white and African American women believe that regular Pap tests are important, although large majorities in all three groups said regular Pap tests are “extremely important.” Of the women surveyed, 85% said women should get Pap tests yearly, and 87% said they had had a Pap test in the past 3 years. However, the survey also found that one in four uninsured women have not had a Pap test in that time frame. The survey was conducted 1 year after the Food and Drug Administration approved a vaccine that protects against four strains of HPV. Women who said they had not heard of the HPV vaccine were excluded from the survey, but more than 90% said they had heard of it.
Vulvodynia Campaign Launched
The Office of Research on Women's Health at the National Institutes of Health has launched a campaign aimed at increasing awareness of vulvodynia, saying that a lack of sufficient consumer and health care provider information may contribute to delayed diagnosis and “the ultimate long-term suffering of vulvodynia patients.” According to NIH, many women suffer with unexplained vulvar pain for months–even years–before a correct diagnosis is made and an appropriate treatment plan is determined. NIH is distributing both consumer- and physician-oriented materials, including frequently asked questions, online and print resources, fact sheets, and scientific articles on vulvodynia, via the campaign Web site,
E-Prescribing Reduces Errors
Electronic prescribing significantly reduced medication errors, according to data from the Southeast Michigan ePrescribing Initiative (SEMI), a coalition of automakers, health plans, providers, a drug manufacturer, and a pharmacy benefits manager. The SEMI results show that among a sample of 3.3 million e-prescriptions, a severe or moderate drug-to-drug alert was sent to physicians for about 33%, resulting in a change to or cancellation of 41% of those scripts by the prescriber. In addition, more than 100,000 medication allergy alerts were presented, of which 41% were acted upon. And, when a formulary alert was presented, 39% of the time the physician changed the prescription to comply with formulary requirements. The SEMI program has generated nearly 6.2 million prescriptions using e-prescribing technology since its launch in February 2005. “The benefits of e-prescribing are overwhelming in terms of reducing medication errors, lowering prescription drug costs for patients and plans, and decreasing physician practices' administrative costs,” said Marsha Manning, General Motors' manager of Southeast Michigan Community Health Care Initiatives, in a statement.